Mr. Hegde is the principal architect for the progress of the group. He holds a Master of Science (MSc) degree in organic chemistry with more than two decades of expertise across domestic and international marketing. His organizational skills and managerial abilities have enabled Lasa group to grow leaps and bounds and spread its wings in the regulated markets across the globe.
In an interaction with Mamta Maity, indiainfoline.com, Shivanand Hegde, Whole-time Director, Lasa Super Generics Ltd said, “We also participate in Chemical and Pharma Ingredients exhibitions (CPHI) and various other conferences all over the world and are already a known brand.”
Tell us about the company's journey so far
Lasa Supergeneticsis one of the fastest-growing API companies in India. The growth experienced by us since inception substantiates it. Lasa started operations in the financial year 2010-11, manufacturing a couple of anthelmintic and veterinary healthcare APIS. The first-year turnover was about 1.0 cr.
In the ten years, since inception, the company has clocked a turnover of Rs. 200 Crores, an increase of about 200 times. This is the result of a planned strategic impetus, envisaging a rapid and multi-dimensional growth. To achieve such an ambitious goal, the Company expanded into a wide range of APIS in veterinary and human space, these encompassed anthelmintic, anti- parasites, antimicrobials and ectoparasiticides.
Multiple plant facilities were added for manufacturing various products in an effective manner. GMP and other registrations for various customers and countries, strengthened with a vibrant marketing strategy has worked great for us and can be seen in the growth we have registered.. The manufacturing process adopted by Lasa in many products is protected with granted patent (Not sure what this means. I think we can remove it).
Lasa recently forayed into manufacturing of Progestrone, a hormone. The Company's noteworthy growth over the years can be attributed to the management’s vision supported by planned and focussed implementation scheme.
Any major impact of Covid-19 pandemic on your operations?
Though the impact of covid 19 is universal, we are least affected, being in the pharmaceutical sector. Our operations are going on with all the necessary protection. Our factories in Konkan region of Maharashtra are in operation with necessary approvals to operate under covid situation. We were slightly affected in transport and shipment of export goods, for a while in April due to lack of transportation. This issue is being solved and everything is getting back to normal as Governmenttookimmediate steps to support the movement of essential goods.
Could you brief us on the outlook and recovery process of your business?
As mentioned earlier, being in pharma sector we are least affected, as of now.
Business outlook for us remains strong with good demand and inherent strength and quality superiority enjoyed by us. We are confident of maintaining growth trajectory during the covid scenario as well. We manufacture key intermediates and important raw materials, ourselves through synthesis, thus are the least dependence on third parties.
As stated earlier, we have commenced the manufacturing of Progestrone, which was being imported. We are trying to identify more such products to support 'Make in India' initiative of the Government.
Who are your major clients? Brief us about company's footprints in India and globally.
We are a major force in Albendazole and Fenbendazole and most end-users and pharma formulators, to the extent about 85% in India, are our clients. We are the preferred choice due to extremely high-quality assurance, prompt fulfilling of commitments, excellent business-friendly strategies and communications. Many top international companies are partnered with under drug master files and cep, as there are signed NDAs, naming them won't be the right thing to do.
We also participate in Chemical and Pharma Ingredients exhibitions (CPHI) and various other conferences all over the world and are already a known brand. Lasa is Also a known brand in local and international markets. We supply products to many end customers around the globe, mainly in Europe, Latin America, Arabic countries and Southeast Asia.
Expected turnover for next quarter
We have consistently posted steady growth year on year, the details of which are posted on our website, from time to time. We are confident that growth trajectory, achieved in last three years YOY, will be maintained and improved with comparatively much lower debts.
Initiatives to help employees and partners.
Covid-19 is an unusual and unfortunate situation for the country and the world. Lasa has been quite sensitive to the fact. We are among early companies to allow office staff to work from home and provided all the necessary work infrastructure at their doorsteps. We also managed to carry out the operations with all prescribed covid care, including safe travels and relevant hygiene.
Working staff are provided with timely rations. We paid salary in full, on time for employees. Society around factory premises was also assisted with providing rations, sanitisers and masks. Donation to State and PM-cares is also done by the company. We have even initiated the development of covid effective antiviral, in our mission to serve mankind.
We have distributed around 10 Lakh doses of Arsenic Album 30, free of cost, to affected areas with the permission of BMC tas our contribution to the society,
Lasa has also taken extra care to execute timely deliveries of its products to the customers to ensure smooth business cycle and availability of formulation medicine of its products, live, in the market in this time of crisis.